The phase 3 ROSELLA trial suggests this combination could become an important new option for patients facing one of the hardest-to-treat forms of ovarian cancer.
#OvarianCancerResearch #Oncology #TCSC
Dual Inhibition of IRE1α and YAP Signaling as a Potential Therapy for Epithelial Ovarian Carcinoma
dl.begellhouse.com/journals/2ff...
#OvarianCancerResearch #IRE1αYAPpathway #TargetedTherapy
Synapse: Your Connection to our MSK Authors
Meet: Matthew Laurence Flint
Research Focus: Graduate Staff; Fellow
#OvarianCancerResearch #FOLR1TargetedTherapy
#Mirvetuximab #ADCTherapy #OncologyOutcomes #TargetedCancerTherapy #GynOnc #CancerResearch
synapse.mskcc.org/synapse/work...
Deciphering Spatially Resolved Pathway Heterogeneity in Ovarian Cancer Post-Neoadjuvant Chemotherapy
Srivastava, A., Vinod, P.
Paper
Details
#OvarianCancerResearch #SpatiallyResolvedPathways #ChemotherapyEffects
#ovariancancer #ovariancancerresearch #ovariancancersurvivor #ovariancancersurvivors #ovariancancerawareness #gyncsm #sgomtg